For this Discussion, review the case
Learning Resources and the case study excerpt presented. Reflect on the case
study excerpt and consider the therapy approaches you might take to assess,
diagnose, and treat the patient’s health needs.
Case: An elderly widow who just lost
her spouse.
Subjective: A patient presents to
your primary care office today with chief complaint of insomnia. Patient
is 75 YO with PMH of DM, HTN, and MDD. Her husband of 41 years passed away
10 months ago. Since then, she states her depression has gotten worse as
well as her sleep habits. The patient has no previous history of
depression prior to her husband’s death. She is awake, alert, and oriented
x3. Patient normally sees PCP once or twice a year. Patient denies
any suicidal ideations. Patient arrived at the office today by private
vehicle. Patient currently takes the following medications:
- Metformin 500mg BID
- Januvia 100mg daily
- Losartan 100mg daily
- HCTZ 25mg daily
- Sertraline 100mg daily
Current weight: 88 kg
Current height: 64 inches
Temp: 98.6 degrees F
BP: 132/86
Post a response to
each of the following:
- List three
questions you might ask the patient if she were in your office. Provide a
rationale for why you might ask these questions.
- Identify people
in the patient’s life you would need to speak to or get feedback from to
further assess the patient’s situation. Include specific questions you
might ask these people and why.
- Explain what, if
any, physical exams, and diagnostic tests would be appropriate for the patient
and how the results would be used.
- List a
differential diagnosis for the patient. Identify the one that you think is
most likely and explain why.
List two pharmacologic agents and their dosing that would be appropriate for the patient’s antidepressant therapy based on pharmacokinetics and pharmacodynamics. From
- a mechanism of
action perspective, provide a rationale for why you might choose one agent
over the other.
- For the drug
therapy you select, identify any contraindications to use or alterations
in dosing that may need to be considered based on the client’s ethnicity.
Discuss why the contraindication/alteration you identify exists. That is,
what would be problematic with the use of this drug in individuals of
other ethnicities?
- Include any “check
points” (i.e., follow-up data at Week 4, 8, 12, etc.), and indicate any
therapeutic changes that you might make based on possible outcomes that
may happen given your treatment options chosen.